GBIO
Price
$0.37
Change
-$0.00 (-0.00%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
24.81M
28 days until earnings call
XBIT
Price
$3.13
Change
+$0.11 (+3.64%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
95.73M
35 days until earnings call
Ad is loading...

GBIO vs XBIT

Header iconGBIO vs XBIT Comparison
Open Charts GBIO vs XBITBanner chart's image
Generation Bio
Price$0.37
Change-$0.00 (-0.00%)
Volume$21.83K
Capitalization24.81M
XBiotech
Price$3.13
Change+$0.11 (+3.64%)
Volume$500
Capitalization95.73M
GBIO vs XBIT Comparison Chart
Loading...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XBIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GBIO vs. XBIT commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GBIO is a StrongBuy and XBIT is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (GBIO: $0.37 vs. XBIT: $3.02)
Brand notoriety: GBIO and XBIT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GBIO: 176% vs. XBIT: 51%
Market capitalization -- GBIO: $24.81M vs. XBIT: $95.73M
GBIO [@Biotechnology] is valued at $24.81M. XBIT’s [@Biotechnology] market capitalization is $95.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GBIO’s FA Score shows that 0 FA rating(s) are green whileXBIT’s FA Score has 1 green FA rating(s).

  • GBIO’s FA Score: 0 green, 5 red.
  • XBIT’s FA Score: 1 green, 4 red.
According to our system of comparison, XBIT is a better buy in the long-term than GBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GBIO’s TA Score shows that 4 TA indicator(s) are bullish while XBIT’s TA Score has 3 bullish TA indicator(s).

  • GBIO’s TA Score: 4 bullish, 4 bearish.
  • XBIT’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, GBIO is a better buy in the short-term than XBIT.

Price Growth

GBIO (@Biotechnology) experienced а -22.23% price change this week, while XBIT (@Biotechnology) price change was -8.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.27%. For the same industry, the average monthly price growth was -7.37%, and the average quarterly price growth was -12.08%.

Reported Earning Dates

GBIO is expected to report earnings on May 01, 2025.

XBIT is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-5.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XBIT($95.7M) has a higher market cap than GBIO($24.8M). XBIT YTD gains are higher at: -23.544 vs. GBIO (-65.075). XBIT has higher annual earnings (EBITDA): -43.6M vs. GBIO (-74.26M). GBIO (185M) and XBIT (183M) have equal amount of cash in the bank . XBIT has less debt than GBIO: XBIT (10M) vs GBIO (93.6M). GBIO has higher revenues than XBIT: GBIO (19.9M) vs XBIT (0).
GBIOXBITGBIO / XBIT
Capitalization24.8M95.7M26%
EBITDA-74.26M-43.6M170%
Gain YTD-65.075-23.544276%
P/E RatioN/AN/A-
Revenue19.9M0-
Total Cash185M183M101%
Total Debt93.6M10M936%
FUNDAMENTALS RATINGS
XBIT: Fundamental Ratings
XBIT
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GBIOXBIT
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 16 days ago
85%
Bullish Trend 17 days ago
70%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 8 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
72%
View a ticker or compare two or three
Ad is loading...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XBIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLDX17.380.53
+3.15%
Celldex Therapeutics
NDAQ78.302.26
+2.97%
Nasdaq
MSGS199.230.87
+0.44%
Madison Square Garden Sports Corp
GTIM2.36-0.02
-0.84%
Good Times Restaurants
EVGO2.65-0.06
-2.21%
EVgo

GBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with ABOS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBIO
1D Price
Change %
GBIO100%
+0.57%
ABOS - GBIO
49%
Loosely correlated
+0.47%
AURA - GBIO
46%
Loosely correlated
+4.76%
ATNM - GBIO
46%
Loosely correlated
+2.01%
ATOS - GBIO
44%
Loosely correlated
+5.62%
FHTX - GBIO
44%
Loosely correlated
+1.33%
More

XBIT and

Correlation & Price change

A.I.dvisor indicates that over the last year, XBIT has been loosely correlated with GBIO. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if XBIT jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XBIT
1D Price
Change %
XBIT100%
-6.79%
GBIO - XBIT
37%
Loosely correlated
-9.11%
ORMP - XBIT
36%
Loosely correlated
-0.47%
AXON - XBIT
34%
Loosely correlated
+2.90%
GOSS - XBIT
31%
Poorly correlated
-9.61%
GLSI - XBIT
31%
Poorly correlated
-2.94%
More